Image Analysis Assesses Immune Reaction to Breast Cancer and Improves Treatment
|
By MedImaging International staff writers Posted on 17 Mar 2015 |
|
A novel test has been developed that can be used to analyze images of “hotspots” where the immune system attacks breast cancer cells.
Scientists used statistical tests to help predict the survival chances of women with breast cancer by assessing the status of their immune system and treated only those in need of intensive treatment. Women with a high number of “hotspots” had a life expectancy of 91 months before their cancer spread while those with fewer hotspots lived 64 months on average.
The scientists analyzed tumor samples from 245 women with estrogen receptor negative (ER negative) breast cancer using computerized imaging and statistical analysis, and measured the number of immune cell hotspots where immune cells were spatially clustered around breast cancer cells. The hotspots were a better indicator of immune response than measuring the number of immune cells in a tumor.
The researchers at the Institute of Cancer Research (London, UK) published details of the test in the February 2015 issue of the journal Modern Pathology.
Team leader in Computational Pathology and Integrative Genomics at the ICR, Dr. Yinyin Yuan, said, “Our research is aiming to develop completely new ways of telling apart more and less aggressive cancers, based on how successful the immune system is in keeping tumors in check. We have shown that to measure the strength of an immune response to a cancer, we need to assess not just how many immune cells there are, but whether these are clustered together into cancer-busting hotspots. By analyzing the complex ways in which the immune system interacts with cancer cells, we can split women with breast cancer into two groups, who might need different types of treatment.”
Definiens (Munich, Germany), which provides image analysis for digital pathology and diagnostics, can discuss what this test means for patients as well as the industry, how this approach is being used in other cancers, challenges with studying the immune system and how they're being addressed, and other advancements expected in immune studies for cancer this year.
Related Links:
The Institute of Cancer Research
Definiens
 Guided Devices.jpg)
Scientists used statistical tests to help predict the survival chances of women with breast cancer by assessing the status of their immune system and treated only those in need of intensive treatment. Women with a high number of “hotspots” had a life expectancy of 91 months before their cancer spread while those with fewer hotspots lived 64 months on average.
The scientists analyzed tumor samples from 245 women with estrogen receptor negative (ER negative) breast cancer using computerized imaging and statistical analysis, and measured the number of immune cell hotspots where immune cells were spatially clustered around breast cancer cells. The hotspots were a better indicator of immune response than measuring the number of immune cells in a tumor.
The researchers at the Institute of Cancer Research (London, UK) published details of the test in the February 2015 issue of the journal Modern Pathology.
Team leader in Computational Pathology and Integrative Genomics at the ICR, Dr. Yinyin Yuan, said, “Our research is aiming to develop completely new ways of telling apart more and less aggressive cancers, based on how successful the immune system is in keeping tumors in check. We have shown that to measure the strength of an immune response to a cancer, we need to assess not just how many immune cells there are, but whether these are clustered together into cancer-busting hotspots. By analyzing the complex ways in which the immune system interacts with cancer cells, we can split women with breast cancer into two groups, who might need different types of treatment.”
Definiens (Munich, Germany), which provides image analysis for digital pathology and diagnostics, can discuss what this test means for patients as well as the industry, how this approach is being used in other cancers, challenges with studying the immune system and how they're being addressed, and other advancements expected in immune studies for cancer this year.
Related Links:
The Institute of Cancer Research
Definiens
X-ray Diagnostic System
FDX Visionary-A
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
NMUS & MSK Ultrasound
InVisus Pro
3T MRI Scanner
MAGNETOM Cima.X
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read more
MRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
Ultrasound-Based Microscopy Technique to Help Diagnose Small Vessel Diseases
Clinical ultrasound, commonly used in pregnancy scans, provides real-time images of body structures. It is one of the most widely used imaging techniques in medicine, but until recently, it had little... Read more
Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a highly promising cancer treatment, especially for bloodborne cancers like leukemia. This highly personalized therapy involves extracting... Read more
Nuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read more
General/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more